These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32320721)

  • 1. The influence of polymeric excipients on desupersaturation profiles of active pharmaceutical ingredients. 1: Polyethylene glycol.
    Schneider R; Taspinar L; Ji Y; Sadowski G
    Int J Pharm; 2020 May; 582():119317. PubMed ID: 32320721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of excipients on solubility and dissolution of pharmaceuticals.
    Paus R; Prudic A; Ji Y
    Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.
    Ji Y; Paus R; Prudic A; Lübbert C; Sadowski G
    Pharm Res; 2015 Aug; 32(8):2559-78. PubMed ID: 25715696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the esterification of active pharmaceutical ingredients containing carboxylic acid functionality in polyethylene glycol: formulation implications.
    Schou-Pedersen AM; Hansen SH; Moesgaard B; Østergaard J
    J Pharm Sci; 2014 Aug; 103(8):2424-33. PubMed ID: 24961667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility of Pharmaceutical Ingredients in Natural Edible Oils.
    Brinkmann J; Rest F; Luebbert C; Sadowski G
    Mol Pharm; 2020 Jul; 17(7):2499-2507. PubMed ID: 32369379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of supersaturation I: indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method.
    Patel DD; Joguparthi V; Wang Z; Anderson BD
    J Pharm Sci; 2011 Jul; 100(7):2623-41. PubMed ID: 21259238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms for the Slowing of Desupersaturation of a Weak Acid at Elevated pH.
    Manchanda A; Li N; Bogner RH
    Mol Pharm; 2020 Oct; 17(10):3759-3772. PubMed ID: 32790317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
    Bochmann ES; Neumann D; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Structurally Related Compounds on Desupersaturation Kinetics of Indomethacin.
    Manchanda A; Bookwala M; Wildfong PLD; Bogner RH
    Pharm Res; 2023 Dec; 40(12):2769-2778. PubMed ID: 37667146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubility of pharmaceutical ingredients in triglycerides.
    Brinkmann J; Huxoll F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2019 Dec; 145():113-120. PubMed ID: 31682903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Silico Screening of Lipid-Based Drug Delivery Systems.
    Brinkmann J; Exner L; Luebbert C; Sadowski G
    Pharm Res; 2020 Nov; 37(12):249. PubMed ID: 33230602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
    Duong TV; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of humidity on the phase behavior of API/polymer formulations.
    Prudic A; Ji Y; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2015 Aug; 94():352-62. PubMed ID: 26117187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic phase behavior of API/polymer solid dispersions.
    Prudic A; Ji Y; Sadowski G
    Mol Pharm; 2014 Jul; 11(7):2294-304. PubMed ID: 24870944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of drug solubility in polymers via differential scanning calorimetry and utilization of the fox equation.
    Haddadin R; Qian F; Desikan S; Hussain M; Smith RL
    Pharm Dev Technol; 2009; 14(1):18-26. PubMed ID: 18825543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state.
    Rathi S; Chavan RB; Shastri NR
    Drug Deliv Transl Res; 2020 Feb; 10(1):70-82. PubMed ID: 31407270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.